---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-029285"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2025-09-17T23:59:59+00:00"
generated_at: "2026-05-17T06:21:23.288481+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics enters $2M secured loan with B. Riley at 10% interest

## Summary
- Agreement with B. Riley Commercial Capital for up to $2.0M secured term loan, maturing Sept 14, 2026 or upon qualified equity raise of $2.4M.
- Interest at 10% per annum; exit fee of $200K (10% of principal) due at maturity.
- Loan may convert into equity in connection with a qualified financing at the lead investor's price.
- Existing $2.0M loan from Banc of California (Pacific Western Bank) terminated and fully paid off.
- Proceeds for working capital and general corporate purposes; secured by substantially all personal property of company and subsidiary.

## SEC filing metadata
- accession: 0001437749-25-029285
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2025-09-17T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/0001437749-25-029285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/ekso20250917_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-029285
- JSON: https://secwatch.observer/filing/0001437749-25-029285.json
- Plain text: https://secwatch.observer/filing/0001437749-25-029285.txt

## Key facts
- Debt Financings
  EKSO BIONICS HOLDINGS, INC. incurred term loan of $2.0 million with B. Riley Commercial Capital, LLC at 10.0% per annum maturing the earlier of the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Company from new equity investors (a “Qualified Financin.
  - Instrument: term loan
  - Principal: $2.0 million
  - Counterparty: B. Riley Commercial Capital, LLC
  - Rate: 10.0% per annum
  - Maturity: the earlier of the receipt of $2.4 million in net proceeds from the sale of the equity interests of the Company from new equity investors (a “Qualified Financin
  - Event: incurrence
  source text: On September 12, 2025, Ekso Bionics Holdings, Inc. (the “Company”) entered into a Secured Promissory Note and Security Agreement (the “Agreement”), by and among the Company, Ekso Bionics, Inc., a Delaware corporation and subsidiary of the Company (the “Subsidiary”), as guarantor, and B. Riley Commercial Capital, LLC, as lender (the “Lender”). The Agreement provides for a secured term loan in an aggregate principal amount of up to $2.0 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000143774925029285/0001437749-25-029285-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.